Company
ALKS · CIK 0001520262
Purchase.
Filer Gilbert Ray Cisneros · Chamber House · District CA31 · Transaction Type Purchase · Asset Type Stock
Traded Jul 29, 2026 · Disclosed Sep 4, 2026FILED +37 DAYS
Source: House Clerk PTR · 20035190 · filed 2026-09-04 · View filing →
Sale of 2,034 shares at $48.01 per share.
Reporting Person Gaffin David Joseph · Officer Title EVP, CLO, Alkermes, Inc. · Transaction Code S
Traded Sep 3, 2026 · Disclosed Sep 3, 2026
Source: SEC Form 4 · 0001520262-26-000120 · filed 2026-09-03 · View filing →
Acquisition (code M) of 5,000 shares at $24.59 per share.
Reporting Person Hopkinson Craig C. · Officer Title EVP R&D, Chief Medical Officer · Transaction Code M
Traded Sep 1, 2026 · Disclosed Sep 1, 2026
Source: SEC Form 4 · 0001520262-26-000118 · filed 2026-09-01 · View filing →
Sale of 9,000 shares at $46.986 per share.
Reporting Person Hopkinson Craig C. · Officer Title EVP R&D, Chief Medical Officer · Transaction Code S
Traded Sep 1, 2026 · Disclosed Sep 1, 2026
Source: SEC Form 4 · 0001520262-26-000118 · filed 2026-09-01 · View filing →
Sale of 6,912 shares at $49.1851 per share.
Reporting Person Nichols Christian Todd · Officer Title SVP, Chief Commercial Officer · Transaction Code S
Traded Aug 17, 2026 · Disclosed Aug 17, 2026
Source: SEC Form 4 · 0001520262-26-000116 · filed 2026-08-17 · View filing →
Sale of 664 shares at $49.6526 per share.
Reporting Person Nichols Christian Todd · Officer Title SVP, Chief Commercial Officer · Transaction Code S
Traded Aug 17, 2026 · Disclosed Aug 17, 2026
Source: SEC Form 4 · 0001520262-26-000116 · filed 2026-08-17 · View filing →